Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2023-02-15 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivatives, and recent dealings. Since this is a specific regulatory disclosure regarding major shareholding interests and dealings during a takeover period, it falls under the 'Major Shareholding Notification' category.
2023-02-15 English
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is specifically used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more during a takeover or merger situation. While it involves share dealings, it is a regulatory requirement for major shareholders/entities during M&A activity rather than a standard 'Major Shareholding Notification' (MRQ) or 'Transaction in Own Shares' (POS). Given the specific context of takeover rules and the disclosure of positions in an offeror/offeree, it falls under the category of Regulatory Filings (RNS) as it is a standard regulatory disclosure form.
2023-02-15 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' filing submitted to the Irish Takeover Panel. This form is specifically used for 'Opening Position Disclosure/Dealing Disclosure' under the Irish Takeover Panel Act, 1997, by persons with interests in relevant securities representing 1% or more during a takeover or merger situation. Since this document details shareholdings and dealings in the context of a takeover (Horizon Therapeutics PLC), it falls under the category of Major Shareholding Notification (MRQ), which covers notifications of significant share ownership levels and changes therein, often triggered by takeover rules.
2023-02-14 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 100% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in an offeror or offeree company (in this case, Mediclinic International PLC). This type of disclosure is a specific regulatory requirement for market surveillance and does not fit into categories like M&A activity (which would be the announcement of the deal itself) or major shareholding notifications (which are typically TR-1 filings). Therefore, it is classified as a Regulatory Filing (RNS).
2023-02-14 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' filing submitted to the Irish Takeover Panel. This form is used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more during a takeover or merger situation. It details shareholdings, derivatives, and recent dealings in the securities of Horizon Therapeutics PLC. This falls under the category of Major Shareholding Notification (MRQ) as it reports significant ownership levels and changes therein, specifically in the context of a takeover.
2023-02-13 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in the securities of Mediclinic International PLC by Citadel Group. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the 'Major Shareholding Notification' category, which covers notifications of significant ownership levels and related disclosures.
2023-02-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.